NCT02090348View on ClinicalTrials.gov

Study to Evaluate Fatigue in Participants With Relapsing Remitting Multiple Sclerosis When Treated With Dimethyl Fumarate

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 30, 2015

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions
Relapsing-Remitting Multiple SclerosisMultiple Sclerosis
Interventions
DRUG

dimethyl fumarate

Administered as specified in the treatment arm

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY